|Articles|May 25, 2022

Promontory Therapeutics Appoints Johan Baeck, MD, as Executive Vice President and Chief Medical Officer

Experienced physician with in-depth expertise in clinical development and immuno-oncology.

Promontory Therapeutics Inc. announced the appointment of Johan Baeck, MD, as Executive Vice President and Chief Medical Officer. Dr. Baeck joins Promontory Therapeutics from Jounce Therapeutics where he served as Senior Vice President, Clinical Development and Medical Affairs.

Read more about the appointment here.

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

Related Content